Literature DB >> 21062763

Improved performance on high-dimensional survival data by application of Survival-SVM.

V Van Belle1, K Pelckmans, S Van Huffel, J A K Suykens.   

Abstract

MOTIVATION: New application areas of survival analysis as for example based on micro-array expression data call for novel tools able to handle high-dimensional data. While classical (semi-) parametric techniques as based on likelihood or partial likelihood functions are omnipresent in clinical studies, they are often inadequate for modelling in case when there are less observations than features in the data. Support vector machines (svms) and extensions are in general found particularly useful for such cases, both conceptually (non-parametric approach), computationally (boiling down to a convex program which can be solved efficiently), theoretically (for its intrinsic relation with learning theory) as well as empirically. This article discusses such an extension of svms which is tuned towards survival data. A particularly useful feature is that this method can incorporate such additional structure as additive models, positivity constraints of the parameters or regression constraints.
RESULTS: Besides discussion of the proposed methods, an empirical case study is conducted on both clinical as well as micro-array gene expression data in the context of cancer studies. Results are expressed based on the logrank statistic, concordance index and the hazard ratio. The reported performances indicate that the present method yields better models for high-dimensional data, while it gives results which are comparable to what classical techniques based on a proportional hazard model give for clinical data.

Entities:  

Mesh:

Year:  2010        PMID: 21062763     DOI: 10.1093/bioinformatics/btq617

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  16 in total

1.  High-dimensional, massive sample-size Cox proportional hazards regression for survival analysis.

Authors:  Sushil Mittal; David Madigan; Randall S Burd; Marc A Suchard
Journal:  Biostatistics       Date:  2013-10-04       Impact factor: 5.899

2.  Large-scale parametric survival analysis.

Authors:  Sushil Mittal; David Madigan; Jerry Q Cheng; Randall S Burd
Journal:  Stat Med       Date:  2013-04-28       Impact factor: 2.373

3.  Nonparametric competing risks analysis using Bayesian Additive Regression Trees.

Authors:  Rodney Sparapani; Brent R Logan; Robert E McCulloch; Purushottam W Laud
Journal:  Stat Methods Med Res       Date:  2019-01-07       Impact factor: 3.021

4.  SurvBenchmark: comprehensive benchmarking study of survival analysis methods using both omics data and clinical data.

Authors:  Yunwei Zhang; Germaine Wong; Graham Mann; Samuel Muller; Jean Y H Yang
Journal:  Gigascience       Date:  2022-07-30       Impact factor: 7.658

5.  Tumor heterogeneity estimation for radiomics in cancer.

Authors:  Ani Eloyan; Mun Sang Yue; Davit Khachatryan
Journal:  Stat Med       Date:  2020-09-23       Impact factor: 2.373

6.  Transcriptional signatures as a disease-specific and predictive inflammatory biomarker for type 1 diabetes.

Authors:  H Levy; X Wang; M Kaldunski; S Jia; J Kramer; S J Pavletich; M Reske; T Gessel; M Yassai; M W Quasney; M K Dahmer; J Gorski; M J Hessner
Journal:  Genes Immun       Date:  2012-09-13       Impact factor: 2.676

7.  Survival Prediction and Feature Selection in Patients with Breast Cancer Using Support Vector Regression.

Authors:  Shahrbanoo Goli; Hossein Mahjub; Javad Faradmal; Hoda Mashayekhi; Ali-Reza Soltanian
Journal:  Comput Math Methods Med       Date:  2016-11-01       Impact factor: 2.238

8.  Learning rule sets from survival data.

Authors:  Łukasz Wróbel; Adam Gudyś; Marek Sikora
Journal:  BMC Bioinformatics       Date:  2017-05-30       Impact factor: 3.169

9.  Big Data Toolsets to Pharmacometrics: Application of Machine Learning for Time-to-Event Analysis.

Authors:  Xiajing Gong; Meng Hu; Liang Zhao
Journal:  Clin Transl Sci       Date:  2018-03-13       Impact factor: 4.689

10.  A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients.

Authors:  Mingguang Shi; R Daniel Beauchamp; Bing Zhang
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.